Federal Supply Schedule 36F79725D0024
Award Date
12/1/24
Last Date to Order
11/30/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
Currax Pharmaceuticals LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Currax Pharmaceuticals LLC. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule program. The contract has a ceiling value of $25,000.00 and a period of performance through November 30, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, grants Carwin Pharmaceutical Associates, LLC the authority to provide $2.5M in pharmaceutical and hematology-related products over a period of 5 years, from September 2024 to September 2029. The contract was awarded on a multiple award basis with no set-asides. As a Federal Supply Schedule contract, this agreement provides a pre-negotiated catalog...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Medicure Pharma Inc. The contract ID is 36F79723D0236 and has a ceiling value of $7,454,790.00. The contract is for the procurement of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" and has an ultimate completion date of September 28, 2028. Medicure Pharma Inc., a for-profit manufacturer of goods, was awarded this multiple-award FSS...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract award to Corium, LLC provides for the procurement of pharmaceutical and drug products under the FSS-61-IB Pharmaceuticals and Drugs schedule. The $2,250,000.00 ceiling value contract has an ultimate completion date of December 14, 2026 and was awarded on December 15, 2021 by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract scope encompasses the supply of drugs, pharmaceuticals, and...
This Federal Supply Schedule contract (FSS-61-IB) was awarded by the U.S. Department of Veterans Affairs (VA) to Trupharma LLC, a for-profit limited liability company, on February 15, 2018. The contract has a ceiling value of $2,000,000.00 and a period of performance ending on July 31, 2025. The contract covers the provision of pharmaceutical and hematology-related products to the VA, which operates as a civilian agency. It is a multiple award schedule, meaning other vendors may also be...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Perrigo Company for the provision of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $506,112,050 and a period of performance from October 1, 2018 to September 30, 2025. The contract is a multiple award Federal Supply Schedule under the Pharmaceuticals and Drugs (FSS-61-IB) program, meaning it is one of several vendors awarded a contract to supply these...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Acelrx Pharmaceuticals, Inc., a for-profit manufacturer of goods. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, with a potential value of $250,000. The period of performance is from August 15, 2019 through the last date to order of August 14, 2024. The contract aims to procure drugs, pharmaceuticals, and...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, to Aquestive Therapeutics, Inc., a for-profit manufacturer of goods and subchapter S corporation. The contract, which has a maximum value of $25,000.00 and a period of performance through March 31, 2025, provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract is a multiple...
The Federal Supply Schedule contract awarded to Apotex Corp. by the Department of Veterans Affairs (VA) under VISN 12 is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This is a multiple award contract with a ceiling value of $23,375,390.00 and a period of performance from September 15, 2024 to September 14, 2029. As a Federal Supply Schedule contract, this vehicle allows the VA and other federal agencies to easily acquire the pharmaceutical and...